Curcumin decreased the high glucose-induced survival of cancer cells upon doxorubicin and methotrexate treatment, suppressed glucose uptake, lactate production, expression of GLUT1/3, MCT1/4, HIF1α, mTOR, STAT3, and multidrug resistance protein MDR-1 [229]. The gene discussed is MTOR; the disease is cancer.